The Hanover Insurance Group, Inc. Declares Quarterly Dividend of $0.90 Per Common Share

The Hanover Insurance Group, Inc. (NYSE: THG) announced today its board of directors has declared a quarterly dividend of $0.90 per share on the issued and outstanding common stock of the company, payable March 28, 2025, to shareholders of record at the close of business on March 14, 2025. https://mma.prnewswire.com/media/511273/The_Hanover_Insurance_Group_Logo.jpg Forward-Looking Statements Statements regarding quarterly […]

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Bridge Investment Group Holdings Inc.

Rowley Law PLLC is investigating potential securities law violations by Bridge Investment Group Holdings Inc. (NYSE: BRDG) and its board of directors concerning the proposed acquisition of the company by Apollo (NYSE: APO). Stockholders will receive 0.07081 shares of Apollo common stock for each share of Bridge Investment stock that they hold. The transaction is

Build Senior Living Calls for Nationwide Assisted Living Reform to Improve Caregiver Accountability

Build Senior Living , a leader in developing and managing high-quality senior living communities, is calling for urgent regulatory reforms to improve workforce stability, protect vulnerable seniors, and ensure the highest standard of care in assisted living communities nationwide. https://mma.prnewswire.com/media/2622781/BSL___Build_Senior_Living___Logo.jpg Build Senior Living calls for a centralized caregiver database to improve senior care. With the

Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

(NASDAQ:CNTX), PHILADELPHIA, Feb. 24, 2025 (GLOBE NEWSWIRE) — Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a biopharmaceutical company advancing medicines for solid tumors, today announced that Context has granted non-qualified stock option awards to purchase an aggregate of 46,000 shares of its common stock to two new employees as an inducement material for

Spin Master Reports Q4 2024 and 2024 Financial Results 2024 Revenue exceeds $2.2 billion, Up 18.8%

Spin Master Corp. (“Spin Master” or the “Company”) (TSX: TOY) www.spinmaster.com), a leading global children's entertainment company, today announced its financial results for the three months and year ended December31, 2024. The Company's full Management's Discussion and Analysis (“MD&A”) for the three months and year ended December31, 2024 is available under the Company's profile on

CRBU Deadline: CRBU Investors Have Opportunity to Lead Caribou Biosciences, Inc. Securities Fraud Lawsuit

Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Caribou Biosciences, Inc. (NASDAQ: CRBU) between July 14, 2023 and July 16, 2024, both dates inclusive (the “Class Period”), of the important February 24, 2025 lead plaintiff deadline. https://mma.prnewswire.com/media/405060/Rosen_Law_Logo.jpg So what: If you purchased Caribou securities during the Class Period you

Jushi Holdings Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025

(CNSX:JUSH),(CNSX:JUSH.CN),(OTC US:JUSHF),(Other OTC:JUSHF), BOCA RATON, Fla., Feb. 24, 2025 (GLOBE NEWSWIRE) — Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator, announced that it expects to report its financial results for the fourth quarter and full year ended December 31, 2024, after the market closes on Thursday,

BioAge Labs, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – BIOA

NEW YORK, NY / ACCESS Newswire / February 24, 2025 / If you suffered a loss on your BioAge Labs, Inc. (NASDAQ:BIOA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/bioage-labs-inc-lawsuit-submission-form?prid=131883&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – REGN

NEW YORK, NY / ACCESS Newswire / February 24, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) between November 2, 2023 and October 30, 2024, both dates inclusive (the "Class Period"), of the important March 10, 2025 lead plaintiff deadline. SO WHAT:

FLAGSTAR FINANCIAL, INC. ANNOUNCES JUNE 4TH DATE FOR ITS 2025 ANNUAL MEETING OF SHAREHOLDERS

Flagstar Financial, Inc. (NYSE: FLG) (the “Company”) today announced that Wednesday, June 4th, has been established as the date of its 2025 Annual Meeting of Shareholders. https://mma.prnewswire.com/media/2543436/Flagstar_Financial_Logo.jpg The meeting will be held in a virtual format only, via live webcast, beginning at 10:00 a.m. Eastern Time. The date of record for voting at the Annual

Scroll to Top